# Filing Detail

Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-232551
Filing Date
2025-10-07
Accepted
2025-10-07 07:05:09
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B5 | 2025_prosupp_pfw_without.htm | 424B5 | 785573
2 | GRAPHIC | img52911964_0.jpg | GRAPHIC | 3030
3 | GRAPHIC | img52911964_1.jpg | GRAPHIC | 77352
4 | GRAPHIC | img52911964_2.jpg | GRAPHIC | 416226
5 | GRAPHIC | img52911964_3.jpg | GRAPHIC | 454986
6 | GRAPHIC | img52911964_4.jpg | GRAPHIC | 203895
7 | GRAPHIC | img52911964_5.jpg | GRAPHIC | 26591
8 | GRAPHIC | img52911964_6.jpg | GRAPHIC | 1935
| Complete submission text file | 0001193125-25-232551.txt |  | 2417460

Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285609 | Film No.: 251378240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)